Healthcare - Biotechnology - NASDAQ - AU
$ 0.2911
-8.11 %
$ 5.68 M
Market Cap
-0.16
P/E
BALANCE SHEET
27.6 M
ASSETS
10.2 M
LIABILITIES
17.5 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Bionomics Limited
| Current Assets | 13.2 M |
| Cash & Short-Term Investments | 12.6 M |
| Receivables | 127 K |
| Other Current Assets | 459 K |
| Non-Current Assets | 14.5 M |
| Long-Term Investments | 52.6 K |
| PP&E | 219 K |
| Other Non-Current Assets | 14.2 M |
| Current Liabilities | 3.83 M |
| Accounts Payable | 2.24 M |
| Short-Term Debt | 122 K |
| Other Current Liabilities | 1.46 M |
| Non-Current Liabilities | 6.33 M |
| Long-Term Debt | 118 K |
| Other Non-Current Liabilities | 6.21 M |
Balance Sheet
Millions
| Jun-2024 | Jun-2023 | Jun-2022 | Jun-2021 | Jun-2020 | Jun-2019 | Jun-2018 | Jun-2017 | Jun-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Cash & Cash Equivalents | 12.6 | 12.2 | 23.2 | 21.4 | 3.2 | 9.8 | 18.5 | 33.0 | 33.9 |
| Short Term Investments | 0 | 0 | 0 | 0.3 | 0 | 0.4 | 0 | 0 | 0 |
| Receivables | 0.1 | 0.4 | 4.7 | 0.8 | 40.7 K | 0.6 | 0.5 | 7.6 | 8.2 |
| Inventory | 0 | (0.4) | (4.7) | 1 | 1.13 | 0.5 | 0.4 | 0.3 | 0.3 |
| Other Current Assets | 0.5 | 0.8 | 1.0 | 1.0 | 2.5 | 6.3 | 6.8 | 0.6 | 0.5 |
| Total Current Assets | 13.2 | 13.4 | 28.9 | 23.2 | 5.8 | 17.6 | 26.6 | 41.9 | 43.3 |
| PP&E | 0.2 | 0.3 | 0.5 | 0.7 | 0.7 | 1.8 | 2.0 | 2.0 | 2.1 |
| Intangible Assets | 5.5 | 6.1 | 6.8 | 7.5 | 8.1 | 9.0 | 10.0 | 11.0 | 12.0 |
| Goodwill | 8.7 | 8.7 | 8.9 | 9.3 | 8.9 | 9.0 | 9.2 | 9.4 | 9.3 |
| Long Term Investments | 52.6 K | 79.2 K | 81.8 K | 89.3 K | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Other Long Term Assets | 26.2 K | (15.2) | (16.1) | (17.4) | (17.7) | (19.8) | (21.3) | (22.5) | (23.3) |
| Other Assets | 0 | 79.3 K | 82.2 K | 89.2 K | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Total Assets | 27.6 | 28.6 | 45.1 | 40.7 | 23.8 | 37.7 | 48.2 | 64.6 | 66.9 |
| LIABILITIES | |||||||||
| Accounts Payable | 2.2 | 1.4 | 1.1 | 0.8 | 0.9 | 0.8 | 2.6 | 95.6 K | 2.0 |
| Short Term Debt | 0.1 | 0.1 | 0.1 | 0.1 | 4.1 | 5.9 | 4.3 | 6.5 | 2.9 |
| Other Current Liabilities | 1.5 | 1.2 | 1.1 | 0.9 | 0.8 | 2.8 | 2.8 | 4.0 | 3.6 |
| Total Current Liabilities | 3.8 | 2.8 | 2.3 | 1.8 | 5.7 | 9.7 | 9.8 | 10.7 | 8.5 |
| Long Term Debt | 0.1 | 0.2 | 0.4 | 0.5 | 4.3 | 6.1 | 11.6 | 7.7 | 13.8 |
| Deferred Tax Income | 1.0 | 1.1 | 1.2 | 1.4 | 1.5 | 2.1 | 2.2 | 3.7 | 3.8 |
| Other Liabilities | 5.2 | 2.5 | 1.9 | 2.7 | 5.0 | 10.3 | 14.1 | 15.2 | 11.8 |
| Total Liabilities | 10.2 | 6.6 | 5.8 | 5.0 | 15.0 | 26.1 | 35.6 | 33.5 | 34.0 |
| EQUITY | |||||||||
| Common Stock | 0 | 148.8 | 150.3 | 142.6 | 102.2 | 101.8 | 100.1 | 103.4 | 100.1 |
| Retained Earnings | (178.0) | (136.4) | (119.7) | (115.5) | (102.8) | (99.7) | (97.2) | (83.2) | (75.6) |
| Other Accumulative Comprehensive Income/Loss | (3.0) | 9.7 | 8.6 | 8.6 | 9.2 | 9.6 | 9.7 | 10.8 | 8.4 |
| Total Equity | 17.5 | 22.1 | 39.3 | 35.7 | 8.8 | 11.6 | 12.6 | 31.1 | 32.9 |
| Total Liabilities and Equity | 27.6 | 28.6 | 44.9 | 40.7 | 23.7 | 37.7 | 48.1 | 64.5 | 66.9 |
| SHARES OUTSTANDING | |||||||||
| Common Shares Outstanding | 10.0 | 1 468.6 | 1 353.2 | 779.9 | 544.8 | 521.3 | 267.9 | 267.4 | 254.0 |